XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables)
 9 Months Ended
Sep. 30, 2023
Revenue from Contract with Customer [Abstract]  
Schedule of Changes in Contract Assets and Contract Liabilities
The following table summarizes the changes in the contract asset and liability balances for the nine months ended September 30, 2023:
Dollars in thousandsTotal
Contract Asset
Contract asset, January 1, 2023
$10,122 
Transferred to trade receivable from contract asset included in beginning of the year contract asset(7,743)
Written off from beginning of the year contract asset due to Boston recall(2,379)
Contract asset, net of transferred to trade receivables on contracts during the period10,392 
Contract asset, September 30, 2023
$10,392 
Contract Liability
Contract liability, January 1, 2023
$16,127 
Recognition of revenue included in beginning of year contract liability$(6,159)
Contract liability, net of revenue recognized on contracts during the period6,282 
Foreign currency translation(51)
Contract liability, September 30, 2023
$16,199 
Schedule of Disaggregation of Revenue
The following table presents revenues disaggregated by the major sources of revenues for the three and nine months ended September 30, 2023 and 2022 (dollar amounts in thousands):
Three Months Ended September 30, 2023Three Months Ended September 30, 2022Nine Months Ended September 30, 2023Nine Months Ended September 30, 2022
Neurosurgery$209,229 $193,848 $607,902 $588,818 
Instruments58,976 55,948 179,469 166,149 
Total Codman Specialty Surgical268,205 249,796 787,371 754,967 
Wound Reconstruction and Care88,071 104,625 280,129 304,149 
Private Label26,145 30,770 77,034 100,528 
Total Tissue Technologies114,216 135,395 357,163 404,677 
Total revenue$382,421 $385,191 $1,144,534 $1,159,644